Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference
Senseonics Holdings (NYSE American: SENS), a medical technology company specializing in long-term, implantable continuous glucose monitoring (CGM) systems for diabetes patients, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston, MA.
The company will deliver a corporate overview and conduct one-on-one meetings during the conference on Tuesday, March 4, 2025, at 3:10 pm ET. Interested parties can access both live and recorded webcasts of the presentation through the 'Investor Relations' section of Senseonics' website at www.senseonics.com.
Senseonics Holdings (NYSE American: SENS), un'azienda di tecnologia medica specializzata in sistemi di monitoraggio continuo della glicemia (CGM) impiantabili a lungo termine per pazienti diabetici, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen a Boston, MA.
L'azienda presenterà una panoramica aziendale e condurrà incontri individuali durante la conferenza martedì 4 marzo 2025, alle 15:10 ET. Le parti interessate possono accedere sia alle trasmissioni in diretta che a quelle registrate della presentazione attraverso la sezione 'Relazioni con gli Investitori' del sito web di Senseonics all'indirizzo www.senseonics.com.
Senseonics Holdings (NYSE American: SENS), una empresa de tecnología médica especializada en sistemas de monitoreo continuo de glucosa (CGM) implantables a largo plazo para pacientes diabéticos, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen en Boston, MA.
La empresa ofrecerá una visión general corporativa y realizará reuniones individuales durante la conferencia el martes 4 de marzo de 2025, a las 3:10 pm ET. Las partes interesadas pueden acceder tanto a las transmisiones en vivo como a las grabadas de la presentación a través de la sección 'Relaciones con Inversores' en el sitio web de Senseonics en www.senseonics.com.
센소닉스 홀딩스 (NYSE American: SENS)는 당뇨병 환자를 위한 장기 이식 가능한 지속적인 혈당 모니터링(CGM) 시스템을 전문으로 하는 의료 기술 회사로, TD 코웬 제45회 연례 건강 관리 컨퍼런스에 참여한다고 발표했습니다.
회사는 2025년 3월 4일 화요일 오후 3시 10분 ET에 컨퍼런스 동안 기업 개요를 제공하고 일대일 미팅을 진행할 예정입니다. 관심 있는 분들은 www.senseonics.com의 '투자자 관계' 섹션을 통해 발표의 실시간 및 녹화된 웹캐스트에 접속할 수 있습니다.
Senseonics Holdings (NYSE American: SENS), une entreprise de technologie médicale spécialisée dans les systèmes de surveillance continue de la glycémie (CGM) implantables à long terme pour les patients diabétiques, a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen à Boston, MA.
L'entreprise présentera un aperçu de l'entreprise et organisera des réunions individuelles lors de la conférence le mardi 4 mars 2025, à 15h10 ET. Les parties intéressées peuvent accéder aux webdiffusions en direct et enregistrées de la présentation via la section 'Relations avec les Investisseurs' du site Web de Senseonics à l'adresse www.senseonics.com.
Senseonics Holdings (NYSE American: SENS), ein Medizintechnikunternehmen, das sich auf langfristige, implantierbare kontinuierliche Glukoseüberwachungssysteme (CGM) für Diabetespatienten spezialisiert hat, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston, MA, bekannt gegeben.
Das Unternehmen wird während der Konferenz am Dienstag, den 4. März 2025, um 15:10 Uhr ET eine Unternehmensübersicht präsentieren und Einzelgespräche führen. Interessierte können sowohl Live- als auch aufgezeichnete Webcasts der Präsentation über den Bereich 'Investor Relations' auf der Website von Senseonics unter www.senseonics.com abrufen.
- None.
- None.
GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming TD Cowen 45th Annual Health Care Conference, being held in Boston, MA.
TD Cowen 45th Annual Health Care Conference
Format: Corporate overview and one-on-one meetings
Date: Tuesday, March 4, 2025
Time: 3:10 pm ET
Webcast: Click here
Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
FAQ
When is Senseonics (SENS) presenting at the TD Cowen Health Care Conference 2025?
How can investors watch Senseonics' (SENS) presentation at the TD Cowen conference?
What type of presentation will Senseonics (SENS) deliver at the TD Cowen conference?
Where is the TD Cowen Health Care Conference featuring Senseonics (SENS) being held?
